The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
about
Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesisIdentification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packagingStructural determinants and mechanism of HIV-1 genome packagingLARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associatedEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationSecondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retrovirusesPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoRole of the DIS hairpin in replication of human immunodeficiency virus type 1The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresThe retroviral RNA dimer linkage: different structures may reflect different rolesThe Life-Cycle of the HIV-1 Gag-RNA ComplexIdentification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitroThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneAntisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cellsAn intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particlesLive-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses.Analysis of the initiating events in HIV-1 particle assembly and genome packagingThe bovine leukemia virus encapsidation signal is composed of RNA secondary structures.cis-Acting sequences required for simian foamy virus type 1 vectorsRotavirus RNA replication requires a single-stranded 3' end for efficient minus-strand synthesis.A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activityThe human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS.An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus.Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidationNovel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesCurrent perspectives on RNA secondary structure probing.Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies.Inhibition of 5'-UTR RNA conformational switching in HIV-1 using antisense PNAs.Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site.Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs.Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.Strong epistatic selection on the RNA secondary structure of HIVRibozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell linesRNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
P2860
Q24498694-6186C85D-75A2-43F3-8D8F-33C0F2221DF0Q24622200-974F0196-365D-4E6C-AE4E-DB7BA9B19F34Q24632055-7575686F-E94A-4A2D-B334-DE514F1C3C2EQ24646322-E84A7E88-7935-4B9C-9331-F3D042E40372Q24673792-D2D31B56-081D-4E17-8F99-FA5665C75B1BQ24675715-153041CA-E6CF-4384-A058-AB95DF6DA40DQ24678656-CB61EEC4-08B7-496F-B577-9D977EA35DD6Q24680551-A69F0E65-627D-4332-9DB2-430799475067Q24682817-C28CE588-2F64-46A0-99ED-180FF5FCAEA8Q24805913-A89AFCA6-327E-4557-ADFB-6A08B0B95DB5Q28076985-5F2AFD02-1BBD-4AD2-B05D-BE7C43B37AB4Q28254442-2492E13D-3228-4CD2-B515-922E790CD0E7Q28301200-EA5AA87A-E36F-4808-8D08-B04F1D2BFA2EQ28369354-8D4FEB8C-BE10-4AAB-8250-6919D4C6456BQ30303886-ACD5381D-6FD8-47EE-AD2B-157053F4F614Q30430249-83CDA908-2A66-4855-BA07-2EADF19D5EABQ30491615-9A56FDF2-3352-469F-9A1A-DC80327DF7BEQ30495474-5CE269E1-A6E9-4881-98AE-FA1C4E7978C3Q30992792-F3B5D87D-A750-4A48-9A95-EC25D1908B93Q33783331-EA1F7E6A-C01F-40B6-A30C-1D15E6B28302Q33783544-557EB14B-2B35-43E4-B31C-8DD410CCED99Q33783864-E019AA4C-3101-4210-9C09-2FE6FCCC831CQ33795610-B5D11049-D87B-4382-8DD3-B8F10DEC7B78Q33805882-2773C50A-FD9C-4E7F-A217-38458D100CCDQ33818125-FFB3E0ED-8C46-4D50-99B2-E3A427FCD3B6Q33850330-D3925A5F-7D70-4D42-BAED-3975FB08CD35Q33850342-0B35E699-54D9-446C-B21D-E145780A655DQ33854807-04F90E7F-792D-4AF3-97BE-07FBDD3D38E4Q33865700-8E210C0B-8002-4C6A-9C5D-AB82318053F7Q34027515-E9E38C07-DB69-468C-815D-A3BC707AC5B3Q34112867-D9BFFBFC-7F60-42B1-98D6-2F6D3A0B34E6Q34477931-242D00A8-F608-4C42-944B-06B9A287C0FAQ34671582-1417DE9D-8615-4C7C-8382-AA36193815DEQ34671913-3C92A07E-EC45-42AB-981C-E5E6CC0E6EC3Q34673247-13942287-A8A8-4B43-9CB6-A4C8432F18EBQ34800316-6AC4CD49-9C3D-4520-A02A-3725F3832699Q35188470-EEB17DAD-E732-4CA0-8CB0-4741FFD13DFBQ35247429-09F267B2-8CAE-468D-B2B2-9C2BFF1A6A3BQ35808611-9BE39D2E-F6D3-4BE7-97CD-026365BC5FDFQ35837228-620EEEB8-686E-4B33-8F47-3304B320A101
P2860
The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The human immunodeficiency vir ...... ed stable secondary structure.
@ast
The human immunodeficiency vir ...... ed stable secondary structure.
@en
The human immunodeficiency vir ...... ed stable secondary structure.
@nl
type
label
The human immunodeficiency vir ...... ed stable secondary structure.
@ast
The human immunodeficiency vir ...... ed stable secondary structure.
@en
The human immunodeficiency vir ...... ed stable secondary structure.
@nl
prefLabel
The human immunodeficiency vir ...... ed stable secondary structure.
@ast
The human immunodeficiency vir ...... ed stable secondary structure.
@en
The human immunodeficiency vir ...... ed stable secondary structure.
@nl
P2860
P1433
P1476
The human immunodeficiency vir ...... ed stable secondary structure.
@en
P2093
P2860
P304
P407
P577
1992-07-01T00:00:00Z